Shuyi Si
- Molecular Biology top 5%
- Pharmacology top 0.5%
- Surgery top 5%
- Pharmacology top 0.5%
- Cancer Research top 5%
- Topics
- Peroxisome Proliferator-Activated Receptors (21 papers)Cholesterol and Lipid Metabolism (17 papers)Drug Transport and Resistance Mechanisms (16 papers)
- Cited by
- PharmacologyCancer Research
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Shuyi Si
84 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 1.9k
- Pharmacology 1.3k
- Surgery 613
- Pharmacology 543
- Cancer Research 477
Countries citing papers authored by Shuyi Si
This map shows the geographic impact of Shuyi Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuyi Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuyi Si more than expected).
Fields of papers citing papers by Shuyi Si
This network shows the impact of papers produced by Shuyi Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuyi Si. The network helps show where Shuyi Si may publish in the future.
Co-authorship network of co-authors of Shuyi Si
This figure shows the co-authorship network connecting the top 25 collaborators of Shuyi Si. A scholar is included among the top collaborators of Shuyi Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuyi Si. Shuyi Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 9 | |
| 5 | 7 | |
| 6 | 8 | |
| 7 | 17 | |
| 8 | 2 | |
| 9 | 23 | |
| 10 | 38 | |
| 11 | 25 | |
| 12 | 32 | |
| 13 | 59 | |
| 14 | 6 | |
| 15 | 13 | |
| 16 | 54 | |
| 17 | Establishment of a high-throughput screening model for identifying up-regulator of human Apo A-I expression | 1 |
| 18 | 34 | |
| 19 | A cell-based high-throughput screening assay for Farnesoid X receptor agonists. | 5 |
| 20 | 15 |
About Shuyi Si
Shuyi Si is a scholar working on Oncology, Molecular Biology and Geriatrics and Gerontology, having authored 86 papers that have together received 3.5k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (21 papers), Cholesterol and Lipid Metabolism (17 papers) and Drug Transport and Resistance Mechanisms (16 papers). The work is most often cited by research in Pharmacology (1.3k citations), Pharmacology (543 citations) and Cancer Research (477 citations). Shuyi Si has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhuorong Li, Weijia Kong, Jing Wei, Yanni Xu, Jian‐Dong Jiang, Bin Hong, Parveen Abidi, Yanling Wang, Satoru Inaba and Shukui Wang. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.